Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease.

Kishnani PS, Corzo D, Leslie ND, Gruskin D, Van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, Bauer MS, Jokic M, Tsai CE, Tsai BW, Morgan C, O'Meara T, Richards S, Tsao EC, Mandel H.

Pediatr Res. 2009 Sep;66(3):329-35. doi: 10.1203/PDR.0b013e3181b24e94.

2.

A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.

Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M, Kooijmans-Coutinho MF, Tsao EC, Sandrock AW; European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators.

Neurology. 2002 Nov 26;59(10):1507-17.

PMID:
12451189
3.

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators.

Neurology. 2002 Sep 10;59(5):679-87.

PMID:
12221157
4.

Angiographic approach to the difficult aortic arch: a new technique for transfemoral cerebral angiography in the aged.

Simmons CR, Tsao EC, Thompson JR.

Am J Roentgenol Radium Ther Nucl Med. 1973 Nov;119(3):605-12. No abstract available.

PMID:
4758333

Supplemental Content

Support Center